Article Information
History
- October 25, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Stefan Mutter1,2,3,
- Erkka Valo1,2,3,
- Viljami Aittomäki4,
- Kristian Nybo4,
- Lassi Raivonen4,
- Lena M Thorn1,2,3,5,
- Carol Forsblom1,2,3,
- Niina Sandholm1,2,3,
- Peter Würtz4 and
- Per-Henrik Groop1,2,3,6,*
- 1Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland
- 2Abdominal Center, Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- 3Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland
- 4Nightingale Health Ltd, Helsinki, Finland
- 5Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- 6Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia
- ↵*Corresponding author: Professor Per-Henrik Groop, Folkhälsan Research Center, Biomedicum Helsinki, Haartmaninkatu 8, FIN-00290 Helsinki, Finland, per-henrik.groop{at}helsinki.fi
Posted October 25, 2020.
Urinary metabolite profiling identifies biomarkers for risk of progression of diabetic nephropathy in 2,670 individuals with type 1 diabetes
